missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Cytiva HyClone™ VaccineXpress Liquid Medium
Description
- VaccineXpress medium is well suited for use in multi-well plates and large‐scale manufacturing using microcarriers in WAVE Bioreactor or Xcellerex bioreactors.
- Serum-free animal-derived component-free formulation.
- Supports direct or sequential adaptation, cell growth and virus propagation.
- Designed to support high peak cell density, viral infectivity, and productivity.
- For use with multiple viral applications (i.e., influenza, rotavirus, RSV, Dengue, Zika).
- Designed for small- to large-scale cell culture applications with use of microcarriers.
- Available in liquid and powder formulations.
- HyClone VaccineXpress medium has been qualified to grow attachment‐dependent Vero cells with microcarriers for producing viral vaccines.
- The lack of both serum and animal‐derived components in the medium reduces variability and enhances scalability and ease of purifying recombinant proteins and viruses in bioprocess applications.
- VaccineXpress is formulated without L‐glutamine for extended shelf life.
Specifications
Specifications
| Classification | Animal Origin, Serum-free, Component-free |
| Form | Liquid |
| Product Type | Cell Culture Medium |
| Serum Level | Serum-free |
| Sterility | Sterile-filtered |
| Sterilization Method | 0.2 μm Sterile-filtered |
| With Additives | Sodium Bicarbonate |
| Without Additives | No Glutamine, No Poloxamer 199, No Phenol Red |
| For Use With (Application) | Designed for small- to large-scale cell culture applications with use of microcarriers. |
| Quantity | 1 L |
| Show More |
Nom du produit
En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.
Vous avez repéré une opportunité d'amélioration ?